The value of friends in a battle: Terry Kalley and the Genentech Avastin battle with the FDA

On December 16, 2010, the FDA issued a press release regarding the Genentech drug Avastin. The headline to the release says it all: FDA begins process to remove breast cancer indication from Avastin label:¬†Drug not shown to be safe and effective in breast cancer patients On Genentech’s side are Washington lawyers, lobbyists and a national … Continue reading